Is FBXO7 c.417+295T>C pathogenic?

FBXO7 c.417+295T>C is classified Benign in FBXO7 (ClinVar, Single submitter, 1 submitter; last evaluated 2018-08-25). Common (popmax 10.4%, nfe) — too common for a highly-penetrant pathogenic allele.

FBXO7 c.417+295T>C

Q: How common is FBXO7 c.417+295T>C in the general population?

FBXO7 c.417+295T>C is common (popmax 10.4%, nfe) — too common for a highly-penetrant pathogenic allele (gnomAD).

rs8135209 · VCV1267845

Benign Single submitter

Classification

Benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Common

common (popmax 10.4%, nfe) — too common for a highly-penetrant pathogenic allele

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
Splice region	donor +295	deep intronic (+295 nt into the intron)
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -1.6	GERP -0.34
Non-coding constraint	Z 0.64	1 kb window · o/e 0.94 · regional · uncalibrated
Overall
CADD	4.643	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 10.4% European (non-Finnish) · 7,091/67,948 alleles

Filtering AF 10.2% ClinGen BA1/BS1 input FAF95, joint · FAF99 10.1%

Overall 8.87% 13,477/151,974 alleles · common

Ancestry group	Frequency	1 in
Amishnot grpmax-eligible	13.2%	8
Finnishnot grpmax-eligible	11.1%	9
European (non-Finnish)grpmax	10.4%	10
Admixed American	8.91%	11
Remaining individualsnot grpmax-eligible	8.4%	12
Middle Eastern	7.82%	13
South Asian	7.63%	13
East Asian	7.51%	13
African / African-American	6.31%	16
Ashkenazi Jewishnot grpmax-eligible	4.7%	21

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: FBXO7
Coding: c.417+295T>C
MANE Select: NM_012179
dbSNP: rs8135209
Type: single nucleotide variant
Location: chr22:32479570 (GRCh38)
Gene constraint: LOEUF 0.955 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure: AlphaFold pLDDT 67.13 · 2 PDB

Full FBXO7 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

FBXO7 p.Arg321Ter Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Arg345Ter Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Arg381Ter Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Arg45Ter Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Arg498Ter Pathogenic ★★ same type
FBXO7 p.Gln237Ter Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Thr22Met Pathogenic/Likely pathogenic ★★ same type
FBXO7 p.Ala84Val Uncertain significance ★★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fbxo7-c-417-plus-295t-c (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown